Author

Sudipta Sonar

Translational Health Science and Technology InstituteORCID 0000-0002-6452-6015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Sankar BhattacharyyaiD· 2 shared Shailendra AsthanaiD· 2 shared Shailendra ManiiD· 2 shared A. Surendranath· 1 shared Abhisek DwivedyiD· 1 shared Anant MohaniD· 1 shared Balwant SinghiD· 1 shared Banwari Lal· 1 shared

Activity by Year

2021-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Sankar BhattacharyyaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 20, 2026

A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants

Diwakar Rathour, Shweta Shrivas, Naresh Kumar…·Jayanta Bhattacharya

This paper identifies a monoclonal antibody from hybrid immunity that broadly neutralizes multiple Omicron variants by targeting conserved epitopes on the spike protein.

DOI 10.64898/2026.07.20.739483

humanproteomics

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedJan 15, 2026

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo

Kamini Jakhar, Sudipta Sonar, Gagandeep Singh…·Shailendra Mani

The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.

12 citationstop 1%

mouseproteomics

𝕏 PostBluesky

BioinformaticsPLoS Computational BiologyPeer-reviewedSep 13, 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad…·Bichitra Kumar Biswal

This study characterizes the NiRAN domain of SARS-CoV-2 RdRp, identifies its kinase-like activity, and predicts potential inhibitors for drug repurposing.

29 citations

virusstatistical model

𝕏 PostBluesky